- Home
- BFLY vs PROK Comparison
BFLY vs PROK Comparison
Compare BFLY & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFLY
- PROK
- Stock Information
- Founded
- BFLY 2011
- PROK 2015
- Country
- BFLY United States
- PROK United States
- Employees
- BFLY N/A
- PROK N/A
- Industry
- BFLY Medical Electronics
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BFLY Health Care
- PROK Health Care
- Exchange
- BFLY Nasdaq
- PROK Nasdaq
- Market Cap
- BFLY 225.5M
- PROK 220.6M
- IPO Year
- BFLY N/A
- PROK N/A
- Fundamental
- Price
- BFLY $3.30
- PROK $1.74
- Analyst Decision
- BFLY
- PROK Buy
- Analyst Count
- BFLY 0
- PROK 5
- Target Price
- BFLY N/A
- PROK $4.50
- AVG Volume (30 Days)
- BFLY 3.8M
- PROK 431.7K
- Earning Date
- BFLY 11-01-2024
- PROK 11-12-2024
- Dividend Yield
- BFLY N/A
- PROK N/A
- EPS Growth
- BFLY N/A
- PROK N/A
- EPS
- BFLY N/A
- PROK N/A
- Revenue
- BFLY $76,221,000.00
- PROK N/A
- Revenue This Year
- BFLY $24.93
- PROK N/A
- Revenue Next Year
- BFLY $18.11
- PROK N/A
- P/E Ratio
- BFLY N/A
- PROK N/A
- Revenue Growth
- BFLY 11.49
- PROK N/A
- 52 Week Low
- BFLY $0.67
- PROK $1.18
- 52 Week High
- BFLY $3.55
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- BFLY 77.19
- PROK 46.63
- Support Level
- BFLY $2.29
- PROK $1.50
- Resistance Level
- BFLY $2.92
- PROK $1.81
- Average True Range (ATR)
- BFLY 0.32
- PROK 0.20
- MACD
- BFLY 0.09
- PROK -0.01
- Stochastic Oscillator
- BFLY 98.60
- PROK 32.26
About BFLY Butterfly Network Inc.
Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.